These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 26830074)

  • 21. Effects of Teraphy with Basal Insulin Analogues Combined with GLP 1 Analogues and Metformin in the Treatment of Obese Patients with Poorly Regulated Postprandial Glycemia.
    Buturovic BA; Ristic LB; Narancic AM
    Med Arch; 2014 Oct; 68(5):313-6. PubMed ID: 25568561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidiabetic agents in patients with chronic kidney disease and end-stage renal disease on dialysis: metabolism and clinical practice.
    Abe M; Okada K; Soma M
    Curr Drug Metab; 2011 Jan; 12(1):57-69. PubMed ID: 21303332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin as an adjunct to insulin for glycemic control in patients with type 2 diabetes after CABG surgery: a randomized double blind clinical trial.
    Baradari AG; Emami Zeydi A; Aarabi M; Ghafari R
    Pak J Biol Sci; 2011 Dec; 14(23):1047-54. PubMed ID: 22590838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of insulin to oral therapy in patients with type 2 diabetes.
    Nelson SE; Palumbo PJ
    Am J Med Sci; 2006 May; 331(5):257-63. PubMed ID: 16702795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications.
    Huri HZ; Lim LP; Lim SK
    Drug Des Devel Ther; 2015; 9():4355-71. PubMed ID: 26300627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia.
    Ebert T; Sattar N; Greig M; Lamina C; Froissart M; Eckardt KU; Floege J; Kronenberg F; Stenvinkel P; Wheeler DC; Fotheringham J
    Am J Kidney Dis; 2024 Jan; 83(1):18-27. PubMed ID: 37657634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.
    Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC
    PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin analogues of patients with diabetes and renal impairment].
    Adamíková A
    Vnitr Lek; 2015 Feb; 61(2):147-50. PubMed ID: 25813259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter, epidemiological study of the treatment patterns, comorbidities and hypoglycemia events of patients with type 2 diabetes and moderate or severe chronic kidney disease - the 'LEARN' study.
    Rombopoulos G; Panitti E; Varounis C; Katsinas C; Stefanidis I; Goumenos D
    Curr Med Res Opin; 2016 May; 32(5):939-47. PubMed ID: 26857244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early intensification of glucose-lowering therapy: VERIFY lessons and real clinical practice on the example of the Moscow region diabetes register data].
    Misnikova IV; Kovaleva YA; Gubkina VA
    Probl Endokrinol (Mosk); 2020 Dec; 66(5):86-95. PubMed ID: 33369376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin treatment in NIDDM patients with mild renal impairment.
    Connolly V; Kesson CM
    Postgrad Med J; 1996 Jun; 72(848):352-4. PubMed ID: 8758014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.
    Crowley MJ; Diamantidis CJ; McDuffie JR; Cameron CB; Stanifer JW; Mock CK; Wang X; Tang S; Nagi A; Kosinski AS; Williams JW
    Ann Intern Med; 2017 Feb; 166(3):191-200. PubMed ID: 28055049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.
    Peyrot M; Rubin RR; Lauritzen T; Skovlund SE; Snoek FJ; Matthews DR; Landgraf R; Kleinebreil L;
    Diabetes Care; 2005 Nov; 28(11):2673-9. PubMed ID: 16249538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metformin in the treatment of type 2 diabetes in overweighted or obese patients].
    Martín Muñoz MC; Díaz JM; Muros Bayo JM; González Alvaro A; Costa Zamora P
    An Med Interna; 2005 Dec; 22(12):579-85. PubMed ID: 16454597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR).
    Arnold SV; Echouffo-Tcheugui JB; Lam CSP; Inzucchi SE; Tang F; McGuire DK; Goyal A; Maddox TM; Sperling LS; Fonarow GC; Masoudi FA; Kosiborod M
    Am Heart J; 2018 Sep; 203():25-29. PubMed ID: 30015065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycaemic Control after Metformin Discontinuation in Diabetic Patients with a Declining Renal Function.
    Leyco T; Ryanputra D; Peh R; Ponce A; Khoo CM
    J Diabetes Res; 2017; 2017():2769819. PubMed ID: 29230420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of metformin in the management of type 2 diabetes: recent advances.
    Gonzalez-Lopez C; Wojeck BS
    Pol Arch Intern Med; 2023 Jun; 133(6):. PubMed ID: 37317976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inpatient Glycemic Management in the Setting of Renal Insufficiency/Failure/Dialysis.
    Iyengar R; Franzese J; Gianchandani R
    Curr Diab Rep; 2018 Aug; 18(10):75. PubMed ID: 30112652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose Management in Hospitalized Patients.
    Kodner C; Anderson L; Pohlgeers K
    Am Fam Physician; 2017 Nov; 96(10):648-654. PubMed ID: 29431385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.
    Hirsch IB; Gaudiani LM
    JAMA; 2020 Jun; 323(23):2419-2420. PubMed ID: 32442246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.